Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HPV testing: where are we now?

A Bovicelli1, R E Bristow, F J Montz

  • 1Department of Gynecology and Obstetrics, S. Orsola Hospital, University of Bologna, Via Massarenti 13, 40138 Bologna, Italy. abovicelli@yahoo.com

Anticancer Research
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer.

Gynecologic oncology·2016
Same author

Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.

Gynecologic oncology reports·2016
Same author

Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.

Current medical research and opinion·2015
Same author

Management of the abnormal papanicolaou smear during pregnancy: lessons for quality improvement.

Journal of lower genital tract disease·2015
Same author

Training cytotechnologists to perform papanicolaou smear screening: development and testing of a third world program.

Journal of lower genital tract disease·2015
Same journal

Corrigendum.

Anticancer research·2026
Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026
Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026
Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026
Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026
Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026
See all related articles

Human papillomavirus (HPV)-DNA testing aids in identifying cervical pre-cancers. It is most valuable for triaging patients with abnormal Pap smears, specifically ASCUS or LG-SIL, to optimize colposcopy referrals.

Area of Science:

  • Gynecology
  • Oncology
  • Molecular Diagnostics

Background:

  • Cervical cancer screening traditionally relies on Pap smears.
  • Advancements in molecular diagnostics offer new approaches to cervical cancer detection.
  • Human papillomavirus (HPV) is a primary cause of cervical pre-cancers and cancer.

Purpose of the Study:

  • To evaluate HPV-DNA testing as a cervical cancer screening tool compared to Pap smears.
  • To determine the utility of HPV-DNA testing as an intermediate triage for ASCUS and LG-SIL Pap smear results.
  • To improve the efficiency of colposcopy resource allocation.

Main Methods:

  • Literature review of peer-reviewed studies from 1992 to June 2000.
  • Analysis of new cervical cancer screening and prevention approaches.

Related Experiment Videos

  • Assessment of HPV-DNA test integration into ASCUS and LG-SIL management protocols.

    • Main Results:

    • HPV-DNA testing combined with Pap smears (conventional or liquid-based cytology) demonstrates high sensitivity and acceptable specificity.
    • This combination effectively identifies patients at higher risk for High-Grade Squamous Intraepithelial Lesions (HG-SIL) requiring colposcopy.
    • HPV-DNA testing serves as a valuable adjunct for cervical cancer screening.

    Conclusions:

    • Current evidence supports HPV-DNA testing as a key triage method for patients with ASCUS and, in certain cases, LG-SIL.
    • This targeted approach enhances the selection of patients who will benefit most from colposcopy.
    • Further research may reveal additional benefits of HPV-DNA testing in broader screening applications.